Along with AMPK-induced inhibition of mTOR signaling which has been shown to trigger the anti-tumorigenic activities of metformin, NT1014 interferes with multiple AMPK-dependent downstream signaling pathways that regulate survival, energy metabolism, oxidative stress, and cell migration in ovarian cancer cells. This evidence concerns the gene MTOR and ovarian carcinoma.